hydroxychloroquine and lactoferrin

hydroxychloroquine has been researched along with lactoferrin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Abers, MS; Alehashemi, S; Bettini, LR; Biondi, A; Bonfanti, P; Brugnoni, D; Burbelo, PD; Calvo, KR; Canna, SW; Castagnoli, R; Castelli, F; Chertow, DW; Cohen, JI; D'Angio', M; de Jesus, AAA; Delmonte, OM; Desai, JV; DiNubile, MJ; Dobbs, K; Fink, DL; Fintzi, J; Gallin, JI; Gliniewicz, EF; Goldbach-Mansky, R; Imberti, L; Kahle, DE; Kuhns, DB; Levinson, SL; Licari, A; Lionakis, MS; Marseglia, GL; Montagna, D; Myint-Hpu, K; Notarangelo, LD; Oikonomou, V; Quiros-Roldan, E; Rastegar, AT; Ricotta, EE; Rossi, C; Shakoory, B; Shaw, E; Sottini, A; Stack, M; Su, HC; Tsang, JS; Zarember, KA	1
Angles-Yanqui, E; Aphang-Lam, M; Carrasco-Escobar, G; Florez, J; Medina, C; Mejia-Cordero, F; Nario, JC; Navarro, R; Ochoa, TJ; Paredes, JL; Quintana, JL; Ruiz-Cabrejos, J; Tucto, L; Turpo-Espinoza, K	1

Studies

Abers, MS; Alehashemi, S; Bettini, LR; Biondi, A; Bonfanti, P; Brugnoni, D; Burbelo, PD; Calvo, KR; Canna, SW; Castagnoli, R; Castelli, F; Chertow, DW; Cohen, JI; D'Angio', M; de Jesus, AAA; Delmonte, OM; Desai, JV; DiNubile, MJ; Dobbs, K; Fink, DL; Fintzi, J; Gallin, JI; Gliniewicz, EF; Goldbach-Mansky, R; Imberti, L; Kahle, DE; Kuhns, DB; Levinson, SL; Licari, A; Lionakis, MS; Marseglia, GL; Montagna, D; Myint-Hpu, K; Notarangelo, LD; Oikonomou, V; Quiros-Roldan, E; Rastegar, AT; Ricotta, EE; Rossi, C; Shakoory, B; Shaw, E; Sottini, A; Stack, M; Su, HC; Tsang, JS; Zarember, KA

Angles-Yanqui, E; Aphang-Lam, M; Carrasco-Escobar, G; Florez, J; Medina, C; Mejia-Cordero, F; Nario, JC; Navarro, R; Ochoa, TJ; Paredes, JL; Quintana, JL; Ruiz-Cabrejos, J; Tucto, L; Turpo-Espinoza, K

Trials

1 trial(s) available for hydroxychloroquine and lactoferrin

Article	Year
Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID). Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2023, Volume: 36, Issue:3 Topics: COVID-19; COVID-19 Vaccines; Delivery of Health Care; Humans; Hydroxychloroquine; Lactoferrin; SARS-CoV-2	2023

Other Studies

1 other study(ies) available for hydroxychloroquine and lactoferrin

Article	Year
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI insight, 2021, 01-11, Volume: 6, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Biomarkers; Calgranulin B; Case-Control Studies; Chemokine CCL2; Chemokine CXCL9; COVID-19; Enzyme Inhibitors; Female; Ferritins; Gene Expression Profiling; Humans; Hydroxychloroquine; Immunologic Factors; Interferon Type I; Interferon-gamma; Interleukin-1 Receptor-Like 1 Protein; Interleukin-10; Interleukin-15; Interleukin-2; Interleukin-6; Lactoferrin; Lipocalin-2; Male; Matrix Metalloproteinase 9; Middle Aged; Multivariate Analysis; NF-kappa B; Prognosis; Receptors, Tumor Necrosis Factor, Type I; SARS-CoV-2; Severity of Illness Index; Vascular Endothelial Growth Factor Receptor-1	2021

Article

Year

An immune-based biomarker signature is associated with mortality in COVID-19 patients.

JCI insight, 2021, 01-11, Volume: 6, Issue:1

Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Biomarkers; Calgranulin B; Case-Control Studies; Chemokine CCL2; Chemokine CXCL9; COVID-19; Enzyme Inhibitors; Female; Ferritins; Gene Expression Profiling; Humans; Hydroxychloroquine; Immunologic Factors; Interferon Type I; Interferon-gamma; Interleukin-1 Receptor-Like 1 Protein; Interleukin-10; Interleukin-15; Interleukin-2; Interleukin-6; Lactoferrin; Lipocalin-2; Male; Matrix Metalloproteinase 9; Middle Aged; Multivariate Analysis; NF-kappa B; Prognosis; Receptors, Tumor Necrosis Factor, Type I; SARS-CoV-2; Severity of Illness Index; Vascular Endothelial Growth Factor Receptor-1

2021